Participate in Share Chat. Set up virtual watchlists and portfolios See more trades and share info.
Register for FREE Now
NoMark
Posted in: IMM
Posts: 2,129
The have basically said the trial was wrong and the drug works. So it’s just a wait to the extended results.
Absolutely. I check in now and again but generally talk to investor relations. Who are very positive in getting it to market.
I believe there are plenty positives on the horizon here. The trial should be positive. Then partner news. That’s why MAP was put on hold .
Happy to hold. NFX playing a blinder for my portfolio
Posted in: NFX
Yes fabulous
Posted in: WDC.L
I think he’ll announce deals l. His credibility will be completely destroyed if he doesn’t
A FAT RAT
Yep
Well it might be the start of a good rise.one bit of good news and this will see 30p at least.
All buys more or less and mms have dropped the price
Absolutely RDR.
Latest end of June
Trial
Remember £10-11 mil for the trail. That as now gone. With prospective partner waiting on extended trial results.
Yes but that’s the cost of phase 3. That’s gone now.
Yes agreed. I do think a partner is being worked on. Best speaking to the company rather than relying on ideal gossip.
Absolutely
A lot of cost for phase 3 trials. Extended results should take the company down the next path, probably with with a corporate partner.
Results
Create a free LSE account to:
Already have an account? Sign In
Don't have an account? Register for FREE